JPWO2022251119A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022251119A5 JPWO2022251119A5 JP2023572165A JP2023572165A JPWO2022251119A5 JP WO2022251119 A5 JPWO2022251119 A5 JP WO2022251119A5 JP 2023572165 A JP2023572165 A JP 2023572165A JP 2023572165 A JP2023572165 A JP 2023572165A JP WO2022251119 A5 JPWO2022251119 A5 JP WO2022251119A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- fold
- antibody
- human
- binding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163192549P | 2021-05-24 | 2021-05-24 | |
| US63/192,549 | 2021-05-24 | ||
| US202163265032P | 2021-12-06 | 2021-12-06 | |
| US63/265,032 | 2021-12-06 | ||
| US202263266453P | 2022-01-05 | 2022-01-05 | |
| US63/266,453 | 2022-01-05 | ||
| PCT/US2022/030556 WO2022251119A2 (en) | 2021-05-24 | 2022-05-23 | Engineered polypeptides |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024521131A JP2024521131A (ja) | 2024-05-28 |
| JPWO2022251119A5 true JPWO2022251119A5 (https=) | 2025-07-03 |
| JP2024521131A5 JP2024521131A5 (https=) | 2025-07-03 |
Family
ID=82156443
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023572165A Pending JP2024521131A (ja) | 2021-05-24 | 2022-05-23 | 操作されたポリペプチド |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20250296986A1 (https=) |
| EP (1) | EP4347642A2 (https=) |
| JP (1) | JP2024521131A (https=) |
| KR (1) | KR20240035758A (https=) |
| AU (1) | AU2022280767A1 (https=) |
| BR (1) | BR112023024494A2 (https=) |
| CA (1) | CA3218489A1 (https=) |
| CL (1) | CL2023003455A1 (https=) |
| CO (1) | CO2023017754A2 (https=) |
| IL (1) | IL308509A (https=) |
| MX (1) | MX2023013859A (https=) |
| TW (1) | TW202306978A (https=) |
| WO (1) | WO2022251119A2 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL299631A (en) | 2020-07-06 | 2023-03-01 | Flagship Pioneering Innovations Vi Llc | Antigen binding molecules targeting sars-cov-2 |
| CA3183367A1 (en) | 2020-07-06 | 2022-01-13 | Gevorg GRIGORYAN | Antigen binding molecules targeting sars-cov-2 |
| KR20230058434A (ko) | 2020-08-26 | 2023-05-03 | 플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨 | SARS-CoV-2를 표적으로 하는 항원 결합 분자 |
| WO2023230439A1 (en) | 2022-05-23 | 2023-11-30 | Vir Biotechnology, Inc. | Fc-engineered hepatitis b virus neutralizing antibodies and uses thereof |
| WO2023245078A1 (en) | 2022-06-15 | 2023-12-21 | Humabs Biomed Sa | Anti-parvovirus antibodies and uses thereof |
| WO2024006472A1 (en) | 2022-06-30 | 2024-01-04 | Vir Biotechnology, Inc. | Antibodies that bind to multiple sarbecoviruses |
| US20260028391A1 (en) | 2022-07-27 | 2026-01-29 | Humabs Biomed Sa | Broadly neutralizing antibodies against rsv and mpv paramyxoviruses |
| WO2024182781A1 (en) | 2023-03-02 | 2024-09-06 | Vir Biotechnology, Inc. | Coronavirus compositions and uses thereof |
| EP4695286A1 (en) | 2023-04-10 | 2026-02-18 | VIR Biotechnology, Inc. | Antibodies that bind to multiple sarbecoviruses |
| WO2025010424A1 (en) | 2023-07-06 | 2025-01-09 | Vir Biotechnology, Inc. | Antibodies against staphylococcus antigens and methods of using the same |
| WO2025015321A1 (en) | 2023-07-13 | 2025-01-16 | Vir Biotechnology, Inc. | Broadly neutralizing antibodies against rsv and mpv paramyxoviruses |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US5959177A (en) | 1989-10-27 | 1999-09-28 | The Scripps Research Institute | Transgenic plants expressing assembled secretory antibodies |
| US5770429A (en) | 1990-08-29 | 1998-06-23 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| WO1993006217A1 (en) | 1991-09-19 | 1993-04-01 | Genentech, Inc. | EXPRESSION IN E. COLI OF ANTIBODY FRAGMENTS HAVING AT LEAST A CYSTEINE PRESENT AS A FREE THIOL, USE FOR THE PRODUCTION OF BIFUNCTIONAL F(ab')2 ANTIBODIES |
| US5789199A (en) | 1994-11-03 | 1998-08-04 | Genentech, Inc. | Process for bacterial production of polypeptides |
| US5840523A (en) | 1995-03-01 | 1998-11-24 | Genetech, Inc. | Methods and compositions for secretion of heterologous polypeptides |
| US6040498A (en) | 1998-08-11 | 2000-03-21 | North Caroline State University | Genetically engineered duckweed |
| US6833268B1 (en) | 1999-06-10 | 2004-12-21 | Abgenix, Inc. | Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions |
| US7125978B1 (en) | 1999-10-04 | 2006-10-24 | Medicago Inc. | Promoter for regulating expression of foreign genes |
| CN100427603C (zh) | 1999-10-04 | 2008-10-22 | 麦迪卡格公司 | 调控外源基因转录的方法 |
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| WO2004076677A2 (en) | 2003-02-26 | 2004-09-10 | Institute For Research In Biomedicine | Monoclonal antibody production by ebv transformation of b cells |
| US20090010920A1 (en) | 2003-03-03 | 2009-01-08 | Xencor, Inc. | Fc Variants Having Decreased Affinity for FcyRIIb |
| EP1676862B1 (en) | 2003-09-24 | 2010-12-22 | Kyowa Hakko Kirin Co., Ltd. | Recombinant antibody against human insulin-like growth factor |
| DK1817340T3 (da) | 2004-11-12 | 2012-08-13 | Xencor Inc | Fc-varianter med ændret binding til fcrn |
| US7612181B2 (en) | 2005-08-19 | 2009-11-03 | Abbott Laboratories | Dual variable domain immunoglobulin and uses thereof |
| WO2008042814A2 (en) | 2006-09-29 | 2008-04-10 | California Institute Of Technology | Mart-1 t cell receptors |
| ES2675730T3 (es) * | 2008-06-04 | 2018-07-12 | Macrogenics, Inc. | Anticuerpos con unión alterada a FcRn y métodos de uso de los mismos |
| JP6173911B2 (ja) | 2010-09-10 | 2017-08-09 | メディミューン リミテド | 抗体誘導体 |
| WO2013163297A1 (en) | 2012-04-25 | 2013-10-31 | Momenta Pharmaceuticals, Inc. | Modified glycoproteins |
| BR112016015140A2 (pt) | 2013-12-30 | 2018-01-23 | Epimab Biotherapeutics Inc. | imunoglobulina com fabs in-tandem e usos das mesmas |
| EP3294774B1 (en) | 2015-05-13 | 2024-08-28 | Zumutor Biologics, Inc. | Afucosylated protein, cell expressing said protein and associated methods |
| WO2019024979A1 (en) | 2017-07-31 | 2019-02-07 | Institute For Research In Biomedicine | FUNCTIONAL DOMAIN ANTIBODIES IN THE ELBOW REGION |
| CN117843810A (zh) | 2017-09-22 | 2024-04-09 | 上海药明生物技术有限公司 | 新型双特异性多肽复合物 |
| US20220298230A1 (en) * | 2019-06-11 | 2022-09-22 | The Rockefeller University | Antibodies and methods for treatment of viral infections |
-
2022
- 2022-05-23 CA CA3218489A patent/CA3218489A1/en active Pending
- 2022-05-23 BR BR112023024494A patent/BR112023024494A2/pt unknown
- 2022-05-23 US US18/563,674 patent/US20250296986A1/en active Pending
- 2022-05-23 IL IL308509A patent/IL308509A/en unknown
- 2022-05-23 MX MX2023013859A patent/MX2023013859A/es unknown
- 2022-05-23 AU AU2022280767A patent/AU2022280767A1/en active Pending
- 2022-05-23 JP JP2023572165A patent/JP2024521131A/ja active Pending
- 2022-05-23 TW TW111119113A patent/TW202306978A/zh unknown
- 2022-05-23 EP EP22732744.2A patent/EP4347642A2/en active Pending
- 2022-05-23 KR KR1020237044483A patent/KR20240035758A/ko active Pending
- 2022-05-23 WO PCT/US2022/030556 patent/WO2022251119A2/en not_active Ceased
-
2023
- 2023-11-21 CL CL2023003455A patent/CL2023003455A1/es unknown
- 2023-12-19 CO CONC2023/0017754A patent/CO2023017754A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230055445A1 (en) | Pd-1 targeted il-15/il-15ralpha fc fusion proteins and uses in combination therapies thereof | |
| US20230331813A1 (en) | TIM-3 TARGETED HETERODIMERIC FUSION PROTEINS CONTAINING IL-15/IL-15RA Fc-FUSION PROTEINS AND TIM-3 ANTIGEN BINDING DOMAINS | |
| US12509495B2 (en) | LAG-3 targeted heterodimeric fusion proteins containing IL-15/IL-15RA Fc-fusion proteins and LAG-3 antigen binding domains | |
| US11932675B2 (en) | PD-1 targeted IL-15/IL-15Rα Fc fusion proteins with improved properties | |
| JP7328761B2 (ja) | 多価多重特異性ｏｘ４０結合融合タンパク質 | |
| JP6696982B2 (ja) | Ｃｄ３および腫瘍抗原に結合するヘテロ二量体抗体 | |
| CN109715663B (zh) | 结合生长抑素受体2的异源二聚抗体 | |
| JP6694446B2 (ja) | Ｃｄ３および腫瘍抗原に結合するヘテロ二量体抗体 | |
| US20240025968A1 (en) | LAG-3 TARGETED HETERODIMERIC FUSION PROTEINS CONTAINING IL-15/IL-15RA Fc-FUSION PROTEINS AND LAG-3 ANTIGEN BINDING DOMAINS | |
| JP2019533444A (ja) | ＩＬ−１５／ＩＬ−１５ＲアルファＦｃ融合タンパク質およびＰＤ−１抗体の断片を含む二重特異性ヘテロ二量体融合タンパク質 | |
| WO2022165443A1 (en) | Chimeric molecules comprising an il-10 or tgf-beta agonist polypeptide | |
| US20220227867A1 (en) | ICOS TARGETED HETERODIMERIC FUSION PROTEINS CONTAINING IL-15/IL-15RA Fc-FUSION PROTEINS AND ICOS ANTIGEN BINDING DOMAINS | |
| CN110267990B (zh) | 结合共刺激性和检查点受体的双特异性免疫调节抗体 | |
| JPWO2022251119A5 (https=) | ||
| CN119365490A (zh) | 结合pd-l1、pd-l2和/或cd28的抗体 | |
| US20250043001A1 (en) | Anti-cd28 compositions | |
| US20250084186A1 (en) | Anti-cd28 x anti-enpp3 antibodies | |
| CN118043356A (zh) | B细胞成熟抗原（bcma）结合结构域组合物 | |
| HK40093127A (zh) | 结合cd3和肿瘤抗原的异二聚体抗体 | |
| WO2026078029A1 (en) | Splitted interleukin-2 prodrugs and uses thereof | |
| HK40065611A (zh) | 结合cd3和肿瘤抗原的异二聚体抗体 |